Search

Your search keyword '"Bunch, Thomas Jared"' showing total 20 results
Start Over Author "Bunch, Thomas Jared"
20 results on '"Bunch, Thomas Jared"'

3. Procedural Volume and Outcomes with Atrial Fibrillation Ablation: A Report from the NCDR AFib Ablation Registry

Author

Kattel, Sharma, primary, Tan, Zhen, additional, Lin, Zhenqiu, additional, Mszar, Reed, additional, Sanders, Prashanthan, additional, Zeitler, Emily P, additional, Zei, Paul C, additional, Bunch, Thomas Jared, additional, Mansour, Moussa, additional, Akar, Joseph G, additional, Curtis, Jeptha P., additional, Friedman, Daniel J., additional, and Freeman, James V., additional

Published
2024
Full Text
View/download PDF

5. Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)

Author

Bunch, Thomas Jared, primary, May, Heidi, additional, Cutler, Michael, additional, Woller, Scott C., additional, Jacobs, Victoria, additional, Stevens, Scott M., additional, Carlquist, John, additional, Knowlton, Kirk U., additional, Muhlestein, Joseph B., additional, Steinberg, Benjamin A., additional, and Anderson, Jeffrey L., additional

Published
2022
Full Text
View/download PDF

6. IMPACT OF ANTICOAGULATION THERAPY ON THECOGNITIVE DECLINE AND DEMENTIA IN PATIENTS WITH NON-VALVULARATRIALFIBRILLATION (CAF) TRIAL

Author

Bunch, Thomas Jared, primary, May, Heidi Thomas, additional, Cutler, Michael J., additional, Woller, Scott C., additional, Jacobs, Victoria, additional, Stevens, Scott, additional, Carlquist, John, additional, Knowlton, Kirk U., additional, Muhlestein, J. Brent, additional, Steinberg, Benjamin Adam, additional, and Anderson, Jeffrey L., additional

Published
2022
Full Text
View/download PDF

10. CATHETER ABLATION COMPARED TO MEDICAL MANAGEMENT FOR ATRIAL FIBRILLATION IN PATIENTS WITH CAROTID ARTERIAL DISEASE IS ASSOCIATED WITH LOWER RATES OF DEMENTIA AND STROKE

Author

Bunch, Thomas Jared, primary, May, Heidi, additional, Bair, Tami, additional, Crandall, Brian G., additional, Cutler, Michael J., additional, Graves, Kevin G., additional, Jacobs, Victoria, additional, Mallender, Charles, additional, Osborn, Jeffrey S., additional, Weiss, J. Peter, additional, and Day, John, additional

Published
2019
Full Text
View/download PDF

15. ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3)

Author

Halperin, Jonathan L., primary, Williams, Eric S., additional, Fuster, Valentin, additional, Halperin, Jonathan L., additional, Cho, Nancy R., additional, Iobst, William F., additional, Mukherjee, Debabrata, additional, Vaishnava, Prashant, additional, Smith, Sidney C., additional, Bittner, Vera, additional, Gaziano, J. Michael, additional, Giacomini, John C., additional, Pack, Quinn R., additional, Polk, Donna M., additional, Stone, Neil J., additional, Wang, Stanley, additional, Balady, Gary J., additional, Bufalino, Vincent J., additional, Gulati, Martha, additional, Kuvin, Jeffrey T., additional, Mendes, Lisa A., additional, Schuller, Joseph L., additional, Narula, Jagat, additional, Chandrashekhar, Y.S., additional, Dilsizian, Vasken, additional, Garcia, Mario J., additional, Kramer, Christopher M., additional, Malik, Shaista, additional, Ryan, Thomas, additional, Sen, Soma, additional, Wu, Joseph C., additional, Berlacher, Kathryn, additional, Lindner, Jonathan R., additional, Mankad, Sunil V., additional, Rose, Geoffrey A., additional, Wang, Andrew, additional, Arrighi, James A., additional, Cohen, Rose S., additional, Miller, Todd D., additional, Solomon, Allen J., additional, Udelson, James E., additional, Blankstein, Ron, additional, Budoff, Matthew J., additional, Dent, John M., additional, Drachman, Douglas E., additional, Lesser, John R., additional, Grover-McKay, Maleah, additional, Schussler, Jeffrey M., additional, Voros, Szilard, additional, Wann, L. Samuel, additional, Hundley, W. Gregory, additional, Kwong, Raymond Y., additional, Martinez, Matthew W., additional, Raman, Subha V., additional, Ward, R. Parker, additional, Creager, Mark A., additional, Gornik, Heather L., additional, Gray, Bruce H., additional, Hamburg, Naomi M., additional, Mohler, Emile R., additional, White, Christopher J., additional, King, Spencer B., additional, Babb, Joseph D., additional, Bates, Eric R., additional, Crawford, Michael H., additional, Dangas, George D., additional, Voeltz, Michele D., additional, Calkins, Hugh, additional, Awtry, Eric H., additional, Bunch, Thomas Jared, additional, Kaul, Sanjay, additional, Miller, John M., additional, Tedrow, Usha B., additional, Jessup, Mariell, additional, Ardehali, Reza, additional, Konstam, Marvin A., additional, Manno, Bruno V., additional, Mathier, Michael A., additional, McPherson, John A., additional, Sweitzer, Nancy K., additional, O’Gara, Patrick T., additional, Adams, Jesse E., additional, Drazner, Mark H., additional, Indik, Julia H., additional, Kirtane, Ajay J., additional, Klarich, Kyle W., additional, Newby, L. Kristen, additional, Scirica, Benjamin M., additional, Sundt, Thoralf M., additional, Warnes, Carole A., additional, Bhatt, Ami B., additional, Daniels, Curt J., additional, Gillam, Linda D., additional, Stout, Karen K., additional, Harrington, Robert A., additional, Barac, Ana, additional, Brush,, John E., additional, Hill, Joseph A., additional, Krumholz, Harlan M., additional, Lauer, Michael S., additional, Sivaram, Chittur A., additional, Taubman, Mark B., additional, and Williams, Jeffrey L., additional

Published
2015
Full Text
View/download PDF

17. ROLE OF PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICES IN UNSTABLE VENTRICULAR ARRHYTHMIA ABLATION

Author

Reddy, Madhu, primary, Mahapatra, Srijoy, additional, Mansour, Moussa, additional, Bunch, Thomas Jared, additional, Swarup, Vijay, additional, Chinitz, Larry, additional, Biase, Luigi Di, additional, Boolani, Hemant, additional, Pillarisetti, Jayasree, additional, Reddy, Namratha, additional, Bommana, Sudharani, additional, Atkins, Donita, additional, Dendi, Raghuveer, additional, Natale, Andrea, additional, and Lakkireddy, Dhanunjaya, additional

Published
2012
Full Text
View/download PDF

18. Reply

Author

Jones, Heath U., primary, Muhlestein, Joseph B., additional, Jones, Kent W., additional, Renlund, Dale G., additional, Bair, Tami L., additional, Bunch, Thomas Jared, additional, Horne, Benjamin D., additional, Lappé, Donald L., additional, Anderson, Jeffrey L., additional, and Doty, Donald B., additional

Published
2006
Full Text
View/download PDF

19. ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3) A Report of the ACC Competency Management Committee

Author

Halperin, Jonathan L., Williams, Eric S., Fuster, Valentin, Cho, Nancy R., Iobst, William F., Mukherjee, Debabrata, Vaishnava, Prashant, Smith, Sidney C., Bittner, Vera, Gaziano, J. Michael, Giacomini, John C., Pack, Quinn R., Polk, Donna M., Stone, Neil J., Wang, Stanley, Balady, Gary J., Bufalino, Vincent J., Gulati, Martha, Kuvin, Jeffrey T., Mendes, Lisa A., Schuller, Joseph L., Narula, Jagat, Chandrashekhar, Y.S., Dilsizian, Vasken, Garcia, Mario J., Kramer, Christopher M., Malik, Shaista, Ryan, Thomas, Sen, Soma, Wu, Joseph C., Berlacher, Kathryn, Lindner, Jonathan R., Mankad, Sunil V., Rose, Geoffrey A., Wang, Andrew, Arrighi, James A., Cohen, Rose S., Miller, Todd D., Solomon, Allen J., Udelson, James E., Blankstein, Ron, Budoff, Matthew J., Dent, John M., Drachman, Douglas E., Lesser, John R., Grover-McKay, Maleah, Schussler, Jeffrey M., Voros, Szilard, Wann, L. Samuel, Hundley, W. Gregory, Kwong, Raymond Y., Martinez, Matthew W., Raman, Subha V., Ward, R. Parker, Creager, Mark A., Gornik, Heather L., Gray, Bruce H., Hamburg, Naomi M., Mohler, Emile R., White, Christopher J., King, Spencer B., Babb, Joseph D., Bates, Eric R., Crawford, Michael H., Dangas, George D., Voeltz, Michele D., Calkins, Hugh, Awtry, Eric H., Bunch, Thomas Jared, Kaul, Sanjay, Miller, John M., Tedrow, Usha B., Jessup, Mariell, Ardehali, Reza, Konstam, Marvin A., Manno, Bruno V., Mathier, Michael A., McPherson, John A., Sweitzer, Nancy K., O’Gara, Patrick T., Adams, Jesse E., Drazner, Mark H., Indik, Julia H., Kirtane, Ajay J., Klarich, Kyle W., Newby, L. Kristen, Scirica, Benjamin M., Sundt, Thoralf M., Warnes, Carole A., Bhatt, Ami B., Daniels, Curt J., Gillam, Linda D., Stout, Karen K., Harrington, Robert A., Barac, Ana, Brush, John E., Hill, Joseph A., Krumholz, Harlan M., Lauer, Michael S., Sivaram, Chittur A., Taubman, Mark B., and Williams, Jeffrey L.

Full Text
View/download PDF

20. Improving CHA 2 DS 2 -VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation.

Author

Graves KG, May HT, Knowlton KU, Muhlestein JB, Jacobs V, Lappé DL, Anderson JL, Horne BD, and Bunch TJ

Abstract

Background: Oral anticoagulation (OAC) therapy guidelines recommend using CHA 2 DS 2 -VASc to determine OAC need in atrial fibrillation (AF). A usable tool, CHA 2 DS 2 -VASc is challenged by its predictive ability. Applying components of the complete blood count and basic metabolic profile, the Intermountain Mortality Risk Score (IMRS) has been extensively validated. This study evaluated whether use of IMRS with CHA 2 DS 2 -VASc in patients with AF improves prediction., Methods: Patients with AF undergoing cardiac catheterisation (N=10 077) were followed for non-fatal stroke and mortality (mean 5.8±4.1 years, maximum 19 years). CHA 2 DS 2 -VASc and IMRS were calculated at baseline. IMRS categories were defined based on previously defined criteria. Cox regression was adjusted for demographic, clinical and treatment variables not included in IMRS or CHA 2 DS 2 -VASc., Results: In women (n=4122, mean age 71±12 years), the composite of non-fatal stroke/mortality was stratified (all p-trend <0.001) by CHA 2 DS 2 -VASc (1: 12.6%, 2: 22.8%, >2: 48.1%) and IMRS (low: 17.8%, moderate: 40.9%, high risk: 64.5%), as it was for men (n=5955, mean age 68±12 years) by CHA 2 DS 2 -VASc (<2: 15.7%, 2: 30.3%, >2: 51.8%) and IMRS (low: 19.0%, moderate: 42.0%, high risk: 65.9%). IMRS stratified stroke/mortality (all p-trend <0.001) in each CHA 2 DS 2 -VASc category., Conclusions: Using IMRS jointly with CHA 2 DS 2 -VASc in patients with AF improved the prediction of stroke and mortality. For example, in patients at the OAC treatment threshold (CHA 2 DS 2 -VASc = 2), IMRS provided ≈4-fold separation between low and high risk. IMRS provides an enhancing marker for risk in patients with AF that reflects the underlying systemic nature of this disease that may be considered in combination with the CHA 2 DS 2 -VASc score., Competing Interests: Competing interests: BDH is an inventor of IMRS and other risk scores that are licensed to CareCentra. BDH is PI of grants funded by Intermountain Healthcare's Foundry innovation program, the Intermountain Research and Medical Foundation, CareCentra, AstraZeneca and GlaxoSmithKline for the development and/or implementation of clinical risk scores. The authors have no other potential conflicts of interest to report.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results